These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Third generation of calcium antagonists: focus on lacidipine].
    Author: Sidorenko BA, Stetsenko TM, Preobrazhenskiĭ DV, Savchenko MV, Soplevenko AV, Shabaeva EN.
    Journal: Kardiologiia; 2002; 42(12):81-90. PubMed ID: 12494025.
    Abstract:
    Similarities and dissimilarities of 3 third generation calcium antagonist (amlodipine, lacidipine and lercanidipine) are presented. Lacidipine is characterized by prolonged antihypertensive action despite its plasma half life is just about 14 hours. Duration of lacidipine effect can be explained by accumulation in lipid bilayer of cellular membranes where it interacts with calcium channels. Pharmacodynamics of lacidipine is discussed in detail as well as experience of its use in hypertension including data of ELSA study which has demonstrated ability of lacidipine to inhibit progression of carotid artery atherosclerosis.
    [Abstract] [Full Text] [Related] [New Search]